{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-034826","form_type":"8-K","ticker":"PDSB","cik":"0001472091","company_name":"PDS Biotechnology Corp","filed_at":"2023-07-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.020870+00:00","generated_at":"2026-06-13T07:36:49.842413+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"PDS Biotechnology shareholders approve 2.4M share increase in equity plan, reelect directors","bullets":["Stockholders approved Third Amended Restated 2014 Equity Plan, increasing authorized shares from 4,165,535 to 6,565,535.","Elected Class B directors Kamil Ali-Jackson and Ilian Iliev; each received >5M votes for, 10M+ broker non-votes.","Ratified KPMG as independent auditor for FY2023 with 17.2M votes for, 259K against.","Non-binding advisory vote on executive compensation approved: 6.0M for, 1.4M against, 10.1M broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-034826","json":"https://secwatch.observer/filing/0001140361-23-034826.json","markdown":"https://secwatch.observer/filing/0001140361-23-034826.md","text":"https://secwatch.observer/filing/0001140361-23-034826.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1472091/000114036123034826/0001140361-23-034826-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1472091/000114036123034826/brhc20055890_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T07:36:49.842413+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3c68ac3fb1d7e7f83543651a70730dcd64ea27f8","claim":"PDS Biotechnology Corp shareholders approved Approval, by non-binding advisory vote, of the compensation of the Company’s named executive officers.","evidence_excerpt":"The Company’s stockholders voted to approve, by non-binding advisory vote, the compensation of the Company’s named executive officers.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036123034826/0001140361-23-034826-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"75b8d5cdbf72be4a5f6eb9629f090bed5da7b478","claim":"PDS Biotechnology Corp shareholders approved Approval of the Third Amended and Restated PDS Biotechnology Corporation 2014 Equity Incentive Plan.","evidence_excerpt":"The Company’s stockholders voted to approve the Third Amended and Restated PDS Biotechnology Corporation 2014 Equity Incentive Plan.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036123034826/0001140361-23-034826-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"9a4a1d042d411a280a4337559525425b6a6aa825","claim":"PDS Biotechnology Corp shareholders approved Ratification of Appointment of KPMG US LLP at the 2023-12-31 meeting.","evidence_excerpt":"The Company’s stockholders ratified the appointment of KPMG US LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036123034826/0001140361-23-034826-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-31"}],"fact_type":"shareholder_vote"},{"claim_id":"9a6c934952a36d01f53a0b5c43bf4169d2801a56","claim":"PDS Biotechnology Corp shareholders approved Election of Class B Directors.","evidence_excerpt":"The Company’s stockholders elected the following directors to serve as Class B directors until the 2026 Annual Meeting of Stockholders of the Company or until their successors are duly elected and qualified.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036123034826/0001140361-23-034826-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}